Site map
- About
- Research and Innovation
- CanFaster
- Publications
- News
- Ongoing CanFaster PhD projects
- Ongoing CanFaster postdoc projects
- Inducing anti-tumor immunity with in-situ direct reprograming of cancer cells to cDC1s
- Next generation immuno-oncological targets for cancer therapy
- Predictive immune biomarkers in cancer
- Targeted imaging and therapies for advanced prostate cancer
- Tracking of mutations in circulating tumour DNA to monitor relapse in breast cancer
- Uncovering prognostic biomarkers in patients with mycosis fungoides and Sézary syndrome using spatial omics
- Finished CanFaster projects
- 3D organoid model development
- Development of new therapies targeting innate immune checkpoints in leukemia
- Head and Neck cancers
- Functional analysis of ‘silent’ mutations in familiar breast cancer
- Functional analysis of the TNFRSF13B multiple myeloma risk allele
- Mantel Cell Lymphoma
- Multiple Myeloma
- Oxygen fluctuations, adult stemness, and phenotypic change – in normal and transformed cells and tissues
- Patient Stratification though Proteomics
- Pediatric Brain Tumor
- Prostate Cancer
- Phosphoproteomic-guided personalized cancer therapy
- Proteomic characterization of ovarian cancer for improved diagnostics
- Psychological Resilience
- Renal Cell Carcinoma
- The role of IL-1 in breast cancer progression and immune evasion
- Therapeutic Targets in Leukemia
- Contact
- Contact
Page Manager: corinna.richter@immun.lth.se | 2023-11-02